Aandelen in “Medische Specialiteiten”

Aandeel Datum Koers Evolutie
vlag Waters Corp. 31/10 349,600 USD
+1,95% 		+1,95%
vlag West Pharmaceutical Services, Inc. 31/10 282,070 USD
+1,27% 		+1,27%

Nieuws over “Medische Specialiteiten”

31/10 · INOVIO Reports Inducement Grant Under Inducement Plan · Persbericht

31/10 · INOVIO Reports Inducement Grant Under Inducement Plan · Persbericht

31/10 · TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) · Persbericht

31/10 · Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules · Persbericht

31/10 · Investors who lost money on Baxter International, Inc.(BAX) should contact Levi & Korsinsky about pending Class Action - BAX · Persbericht

31/10 · Shareholders that lost money on Lantheus Holdings, Inc.(LNTH) should contact Levi & Korsinsky about pending Class Action - LNTH · Persbericht

30/10 · Nyxoah to Release Third Quarter 2025 Financial Results on November 13, 2025 · Persbericht

30/10 · InMode to Participate in Upcoming Investor Conferences · Persbericht

30/10 · Hoag selects Philips to enhance and unify patient monitoring, elevating care across Orange County, USA · Persbericht

30/10 · PAVmed to Hold a Business Update Conference Call and Webcast on November 13, 2025 · Persbericht

30/10 · CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights · Persbericht

30/10 · Envista Reports Third Quarter 2025 Results · Persbericht

30/10 · BAX INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Baxter International, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit · Persbericht

29/10 · Lantheus Holdings, Inc. (LNTH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit · Persbericht

29/10 · Envista Announces Release of 2024 Sustainability Report · Persbericht

29/10 · Artivion to Participate in the Stifel 2025 Healthcare Conference · Persbericht

29/10 · TransMedics Reports Third Quarter 2025 Financial Results · Persbericht

29/10 · Biotechgroep Thermo Fisher legt 9 miljard op tafel voor specialist in klinische studies · Tijd.be (€)

De Amerikaanse groep Thermo Fisher Scientific neemt Clario over, een dienstenleverancier voor klinische studies, voor een bedrag dat kan oplopen tot 9,4 miljard dollar.

29/10 · Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025 · Persbericht

29/10 · Late-breaking iMODERN findings presented at TCT 2025 and published in the New England Journal of Medicine highlight new evidence to guide treatment choices for heart attack patients · Persbericht

29/10 · Fed-besluit en techcijfers bepalen de toon · LYNX

Beursnieuws Amerika De Amerikaanse aandelenmarkten sloten dinsdag opnieuw op recordniveaus in aanloop naar de verwachte renteverlaging van de Federal Reserve. Ook een herstellende handelsrelatie tussen de Verenigde Staten...

Mijn selecties